Core Laboratories Inc
(CLB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 12,680 | 3,490 | 37,025 | 34,591 | 25,371 |
| Depreciation Amortization | 7,613 | 3,843 | 15,784 | 11,910 | 7,981 |
| Income taxes - deferred | -777 | 2,827 | -10,811 | -14,757 | -10,949 |
| Accounts receivable | -7,019 | -6,290 | -2,618 | 2,872 | -103 |
| Accounts payable and accrued liabilities | 3,116 | -551 | -12,878 | -13,101 | -8,685 |
| Other Working Capital | -1,397 | -9,883 | -28,772 | -37,012 | -23,710 |
| Other Operating Activity | 8,460 | 12,094 | 27,059 | 20,857 | 15,667 |
| Operating Cash Flow | $22,676 | $5,530 | $24,789 | $5,360 | $5,572 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,117 | -2,459 | -10,094 | -7,423 | -4,029 |
| Purchase Sale Intangibles | -3 | -3 | 67 | -158 | -164 |
| Other Investing Activity | 2,773 | 802 | 3,442 | 3,217 | 3,211 |
| Investing Cash Flow | $-2,344 | $-1,657 | $-6,652 | $-4,206 | $-818 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 22,000 | 14,000 | 202,000 | 190,000 | 111,000 |
| Debt Repayment | -38,000 | -17,000 | -211,000 | -184,000 | -101,000 |
| Common Stock Repurchased | -206 | -44 | -2,202 | -418 | -200 |
| Dividend Paid | -938 | -468 | -1,868 | -1,401 | -934 |
| Other Financing Activity | -613 | -568 | -5,375 | -4,147 | -2,844 |
| Financing Cash Flow | $-17,757 | $-4,080 | $-18,445 | $34 | $6,022 |
| Beginning Cash Position | 15,120 | 15,120 | 15,428 | 15,428 | 15,428 |
| End Cash Position | 17,695 | 14,913 | 15,120 | 16,616 | 26,204 |
| Net Cash Flow | $2,575 | $-207 | $-308 | $1,188 | $10,776 |
| Free Cash Flow | |||||
| Operating Cash Flow | 22,676 | 5,530 | 24,789 | 5,360 | 5,572 |
| Capital Expenditure | -5,918 | -3,052 | -10,579 | -7,843 | -4,382 |
| Free Cash Flow | 16,758 | 2,478 | 14,210 | -2,483 | 1,190 |